SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics ($MLTX) is trending after a significant drop following mixed results from phase 3 trials, leading to community debate about the severity of the market's reaction. Some investors believe the sell-off is an overreaction, given the company's cash reserves and pipeline, while others cite concerns about commercial viability and existing market competition. Discussions include potential buyout scenarios and the possibility of a short squeeze.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending due to a sharp decline in share price following a controversial, now-retracted, LinkedIn post by a former FDA official questioning the safety and efficacy of their drug, Lupkynis. The community is actively debating the motivations behind the post, potential market manipulation, and the need for a strong response from the company, with some even calling for legal action. Broader discussions include speculation about a potential buyout and frustration with the company's leadership.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as a "culture coin," with the community emphasizing freedom and growth. Discussions revolve around its utility compared to traditional cannabis companies, and where to purchase it. Some users are also discussing potential connections to broader cannabis legalization efforts.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is trending as investors debate whether its recent dip represents a buying opportunity or signals deeper issues, especially in comparison to competitors like Chipotle. The community is actively discussing the impact of the COO's departure and weighing the company's expansion plans against concerns about consumer spending and valuation. Some are optimistic about a potential rebound, citing strong fundamentals and growth potential, while others express caution and suggest further downside.

Applied DNA Sciences, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.

Applied Dna Sciences Inc

Applied DNA Sciences ($APDN) is trending as discussions revolve around its recent private placement to initiate a BNB-focused digital asset strategy, a move that has drawn mixed reactions from the community. Some view the shift towards crypto as a potential game-changer and a way to unlock value, while others express concern about abandoning their DNA technology. Community members are also closely monitoring the company's ticker symbol change to BNBX.

American Exceptionalism Acquisition Corp. A is a blank check company. It was created for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on July 11, 2025 and is headquartered in Menlo Park, CA.

American Exceptionalism Acquisition Corp. A - Ordinary Shares - Class A

American Exceptionalism Acquisition Corp. A

American Exceptionalism Acquisition Corp. A ($AEXA) is trending as the Chamath Palihapitiya-backed SPAC seeks a merger, with speculation focusing on potential targets like Starlink or Discord. The community is expressing both excitement and skepticism, reminiscent of the earlier SPAC boom, while awaiting further news and potential option availability. Bullish sentiment is countered by concerns about the stock's valuation and potential downsides.

Boqii Holding Ltd. operates as a holding company with interest in operating online pet stores. It provides services through its subsidiaries. The company was founded by Liang Hao, Tang Yingzhi, and Chen Di in December 2007 and is headquartered in Shanghai, China.

Boqii Holding Limited - Ordinary Shares - Class A

Boqii Holding Limited - ADR

Boqii Holding is trending due to speculation around low float runners and potential multi-day momentum. The stock's previous performance, coupled with interest in Chinese low-float plays, has fueled community discussions about possible squeezes and high price targets. Some traders are also wary of potential rug pulls or offerings.

EchoStar Corp. engages in the design, development, and distribution of digital set-top boxes and products for direct-to-home satellite service providers. It operates through the following business segments: Pay-TV, Retail Wireless, and Broadband and Satellite Services. The Pay-TV segment business strategy is to be the best provider of video services in the United States by providing products with the best technology, outstanding customer service, and great value. The Retail Wireless segment offers Retail Wireless services as well as a competitive portfolio of wireless devices. The Broadband and Satellite Services segment business strategy is to maintain and improve leadership position and competitive advantage through development of technologies and services marketed to selected sectors within the consumer, enterprise and government markets globally. The company was founded by Charlie William Ergen, Candy Ergen, and James DeFranco in 1980 and is headquartered in Englewood, CO.

EchoStar Corp - Ordinary Shares - Class A

EchoStar Corp

EchoStar ($SATS) is trending amid reports that Verizon is in talks to acquire its wireless spectrum, potentially driving the price over $90. The community is buzzing about a possible short squeeze due to the stock being undervalued and the potential for FCC approval of pending deals. Bullish sentiment is further fueled by speculation of net cash per share reaching $84 after deal completions.

AKIRA LABS

AKIRA.X is trending as the community discusses potential integration or collaboration with SOL.X and WAGMI.X. Many traders are adding AKIRA.X to their watchlists, anticipating potential green candles and inclusion in the current meme cycle. The community seems to be bullish on AKIRA.X, with some highlighting it as a gem.

Bakkt Holdings, Inc. engages in the intersection of cryptoassets, loyalty and rewards, and payments. It also provides a platform to expand payment offerings, create new revenue streams, and increase customer loyalty. The company was founded in 2018 and is headquartered in Alpharetta, GA.

Bakkt Holdings Inc - Ordinary Shares - Class A

Bakkt Holdings Inc

Bakkt Holdings is trending due to renewed interest following news of a new board appointment, sparking discussions about the company's potential growth strategy within the digital asset space. The community is actively speculating about the impact of new leadership and potential partnerships, especially regarding expansion into foreign markets and web3 technologies. Bullish sentiment is building around the possibility of a short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Applied DNA Sciences (APDN) Stock Is Skyrocketing

Applied DNA Sciences has expanded its mpox testing services. Shares rose 37% after the announcement.
read more...

Why Is Diagnostic Tests Provider Applied DNA Sciences Stock Trading Higher On Friday?

Applied DNA Sciences stock surges as it seeks approval to expand its mpox virus test to cover additional clades. The company awaits a decision from NYSDOH following its validation package submission...

Maxim Group Reaffirms Their Hold Rating on Applied DNA Sciences (APDN)

Maxim Group analyst Jason McCarthy maintained a Hold rating on Applied DNA Sciences (APDN Research Report) yesterday. The company's shares closed...

Applied DNA Sciences enters manufacturing agreement with Alphazyme

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start

- Project To Increase RNAP Manufacturing Capacity and Reduce Unit Costs of Goods -- Project Slated for Completion Coincident with Company's Planned Initiation of GMP Manufacturing for Linea(TM) DNA...

Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress

STONY BROOK, NY / ACCESSWIRE / March 14, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, will showcase its Linea(TM) IVT and Linea(TM) DNA...

Q1 2024 Applied DNA Sciences Inc Earnings Call Transcript

Analysts Offer Insights on Healthcare Companies: Applied DNA Sciences (APDN) and Viking Therapeutics (VKTX)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Applied DNA Sciences (APDN Research Report) and Vi...

Applied DNA Sciences price target lowered by 50c at H.C. Wainwright, here's why

Recap: Applied DNA Sciences Q1 Earnings

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

Current Price	$3.93
Prev Close	$4.14
Open	$4.10
Dividend Yield	0.00%
50-Day Moving Average	$3.70
Beta	0.78
Avg. Volume	76,842.90
PE Ratio	0.00

52-Week High	$682.50
52-Week Low	$2.13
Market Capitalization	$5.35M
EPS (Annual)	-$1,366.41
Price to Book	0.51
Revenue Per Employee	$71,487.92
Enterprise Value/EBITDA	N/A

APDN
Applied Dna Sciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest APDN News

APDN Applied Dna Sciences Inc